This translated to sustained momentum in new logo acquisition and customer expansions." On the profitability front, we note that Confluent achieved a record pro forma operating margin of 6% in the ...

The Aspen Idea,” wrote Mortimer Adler, “uniquely demonstrates that in the scale of values the Platonic triad of the good, the ...

MSCI earnings call for the period ending December 31, 2024.

Confluent Health proudly announces the rebranding of IncreMedical Therapy Solutions to Confluent Health System Solutions. This evolution reflects the commitment to partnering with health systems ...

A large Louisville-based health care firm has made a pair of key C-suite appointments. Confluent Health announced this week ...

LOUISVILLE, Ky., Jan. 21, 2025 /PRNewswire/ -- Confluent Health today announced that it has promoted Dr. Stephen Clark, PT, DPT, OCS, ATC to the newly created role of Chief Clinical Officer (CCO ...

Guggenheim raised the firm’s price target on Confluent (CFLT) to $35 from $32 and keeps a Buy rating on the shares. The firm believes Confluent will exceed Q4 subscription revenue by 3% as its ...

LOUISVILLE, Ky., Jan. 21, 2025 /PRNewswire/ -- Confluent Health today announced that it has promoted Dr. Stephen Clark, PT, DPT, OCS, ATC to the newly created role of Chief Clinical Officer (CCO) and ...

In the last three months, 11 analysts have published ratings on Confluent (NASDAQ:CFLT), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...